In accordance with ACR pointers, allopurinol is strongly advised as a first-line urate-reducing medication. Genetic tests is suggested (for just a variant identified as HLA B*5801) previous to beginning allopurinol because the carriers of the gene are at an elevated chance of a intense allergic response.Dos akan dinaikkan secara beransur-ansur sehi